Company intelligence / Profile preview

Medtech Innovative Surgical Technology

Montpellier, France

Ownership: Private
Employees: ~100
Development stage: Other

Overview

Medtech's flagship ROSA™ robotic platforms for brain and spine surgery were CE marked in Europe and FDA-cleared in the US, with clinical adoption in key neurosurgical and minimally invasive spine procedures; substantial data supported their safety and efficacy for stereotactic and minimally invasive approaches prior to acquisition.

Therapeutic areas: Neurology
Modalities: DeviceRobotic surgical system
Industry: Surgical Medical Devices

Partnerships

Zimmer Biomet (strategic partnership/acquisition)Ally Bridge Group (investor/partner)

Beyond the preview

Go deeper on Medtech Innovative Surgical Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Medtech Innovative Surgical Technology.

Explore the full profile